Concepedia

Katherine E. McDonell

KE

Statistics

Publications

12

Citations

429

H-Index

11

Active since

2016

Affiliations

Vanderbilt University Medical Center(Current)

Vanderbilt University

University of Louisville

University of British Columbia

University of Iowa

Katherine E. McDonell is an author at Vanderbilt University Medical Center specializing in huntington disease, pharmacology, and neurology.

ORCID

Publications per year

2016–2024

12

Publications

12

Cortical asymmetry in Parkinson's disease: early susceptibility of the left hemisphere

Daniel O. Claassen, Katherine E. McDonell, Manus J. Donahue et al. · Brain and Behavior · 2016 · 126 citations · Full text

, , +17

Safety and efficacy of valbenazine for the treatment of chorea associated with Huntington's disease (KINECT-HD): a phase 3, randomised, double-blind, placebo-controlled trial

Erin Furr Stimming, Daniel O. Claassen, Elise Kayson et al. · The Lancet Neurology · 2023 · 63 citations

, , +11

Pepinemab antibody blockade of SEMA4D in early Huntington’s disease: a randomized, placebo-controlled, phase 2 trial

Andrew Feigin, Elizabeth E. Evans, Terrence L. Fisher et al. · Nature Medicine · 2022 · 62 citations · Full text

, , +13

Motor speech patterns in Huntington disease

Sarah Diehl, Antje S. Mefferd, Ya‐Chen Lin et al. · Neurology · 2019 · 42 citations · Full text

, , +16

Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study

Ralf Reilmann, Karen E. Anderson, Andrew Feigin et al. · The Lancet Neurology · 2024 · 33 citations · Full text

, , +7

1–5 of 12